Clinical Trial Update: Oral Hypoglycemic Therapy for Monogenic Variant Carriers of the Joslin Medalist Study [Phase 2, Phase 3]

View source ↗

Summary

Phase 2 and Phase 3 clinical testing of an oral hypoglycemic therapy in carriers of monogenic variants within the Joslin Medalist Study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Monogenic Diabetes
• Type 1 Diabetes Mellitus

Drugs mentioned

• Oral hypoglycemic therapy (investigational)

Snippet

Sponsor: Joslin Diabetes Center | Conditions: Type 1 Diabetes, Monogenic Diabetes | Phase 2, Phase 3 | Status: COMPLETED